Program – 62th Days H.P. Klotz – 2019


    

« New insights into the pathophysiology and treatment of Neuroendocrine Tumors« 

Thursday, June 20th, 2019

08H45-09H00 : Introduction

PRECLINICAL MODELS OF NEUROENDOCRINE TUMORS

  • 09H00-09H30: Cell lines and primary cultures
    David Romano, Marseille, France
  • 09H30-10H00: Zebrafish
    Giovanni Vitale, Milan, Italy
  • 10H00-10H30: Murine models
    Natalia Pellegata, Neuherberg, Germany

10H30-11H00 : Coffee break – Posters

PATHOLOGY, GENOMICS AND EPIGENOMICS OF NEUROENDOCRINE TUMORS

  • 11H00-11H30: GEP and thoracic neuroendocrine tumors.
    Aldo Scarpa, Verone, Italy
  • 11H30-12H00: Emerging Molecular Markers of Metastatic Pheochromocytomas and  Paragangliomas
    Luis Jaime Castro-Vega, Paris, France
  • 12H00-12H30: Epigenomics in neuroendocrine tumors.
    Leo Hofland, Rotterdam, The Netherlands

12H30-14H00 : Lunch

DIAGNOSIS OF NEUROENDOCRINE NEOPLASMS

  • 14H00-14H30: Lung and digestive neuroendocrine neoplasms: from WHO classification to biomarker screening: which perspective?
    Jean-Yves Scoazec, Villejuif, France
  • 14H30-15H00: Biomarkers: are hormone validated tumor biomarkers ?
    Wouter de Herder, Rotterdam, The Netherlands
  • 15H00-15H30: Receptor Radionuclide imaging for diagnosis and therapy.
    Frédéric Courbon, Toulouse, France

15H30-16H00 : Coffee break – Posters

PROGRESS IN THE DIAGNOSIS AND MANAGEMENT OF GEP NEOPLASMS

  • 16H00-16H30: Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)
    Louis De Mestier, Paris, France
  • 16H30-17H00: French and ENETS Consensus Guidelines
    Guillaume Cadiot, Reims, France

Friday, June 21st, 2019

DEBATE ON THE TREATMENT OF GEP NEOPLASMS

  • 9H00-9H30: Role of surgery
    Alain Sauvanet. Paris, France
  • 09H30-10H00: Role of radiofrequency ablation
    Marc Barthet. Marseille, France

ORAL COMMUNICATIONS

  • 10H00-10H30: Oral communications

10H30-11H00 : Coffee break

MANAGEMENT OF AGGRESSIVE NEUROENDOCRINE NEOPLASMS: NOVEL PERSPECTIVES IN MEDICAL TREATMENT

  • 11H00-11H30: Aggressive GEP neoplasms
    Romain Coriat, Paris, France
  • 11H30-12H00: Aggressive lung and thymic neoplasms
    Piero Ferolla, Perugia, Italy
  • 12H00-12H30: Malignant Pheochromocytomas and paragangliomas
    Julien Hadoux, Villejuif, France

12H30-14H00 : Lunch

MEDULLARY THYROID CANCER

  • 14H00-14H30: Clinical utility of genetic diagnosis for sporadic and hereditary MTCs
    Rossella Elisei, Pisa, Italy
  • 14H30-15H00: Baseline and stimulated Calcitonin: Thresholds for the diagnosis of medullary thyroid cancer
    Laura Fugazzola, Milan, Italy
  • 15H00-15H30: State of the art of medical therapies
    Eric Baudin, Villejuif, France

MULTIPLE ENDOCRINE NEOPLASIA TYPE 1

  • 15H30-16H00: Update on phenotypes of MEN1 mutation carriers
    Gerlof Valk, Utrecht, The Netherlands
  • 16H00-16H40: ROUND TABLE DISCUSSION: Clinical screening of MEN1 mutations carriers: When and how screening should be performed?
    Discussants: Brigitte Delemer, Reims; Catherine Cardot, Lille; Antoine Tabarin, Bordeaux, France

16H40-16H50 : Conclusion
 

© SFE Janvier 2019